Japan Blood Collection Devices Market Overview, 2031

Japan Blood Collection Devices Market Insight, 2031 Industry Ecosystem Analysis Japan’s blood collection devices ecosystem is supported by a large hospital and diagnostic network, centralized blood services and established domestic medical-device manufacturers. Japan had 179,834 active medical institutions in October 2023, including 8,122 hospitals, 104,894 medical clinics and 66,818 dental clinics, creating a broad base for venous blood collection, specimen handling and diagnostic testing. The Japan Red Cross Society operates 7 block blood centers, 115 blood donation rooms and 271 mobile blood-collection vehicles, connecting donor collection with testing, component preparation and transfusion supply. Terumo, Nipro, Kawasumi Laboratories and other Japanese medical-device companies participate in blood-collection needles, tubes, syringes, blood bags and associated sampling systems, while hospitals such as University of Tokyo Hospital and Osaka University Hospital represent high-volume clinical users. Japan’s blood-collection chain is therefore divided between diagnostic specimen collection and transfusion-oriented collection, with products moving through hospitals, clinics, laboratories and Japanese Red Cross facilities. Tokyo, Osaka, Nagoya and Fukuoka are important healthcare centers, while specialized medical-device manufacturing and logistics connect production sites with hospitals and laboratories nationwide. The ecosystem places strong emphasis on sterility, traceability, low sample-volume requirements and consistent tube additives because laboratory results can be affected by collection technique and specimen handling.

Patent & Innovation Landscape Blood-collection innovation in Japan is increasingly concentrated on safety, sample integrity, reduced blood loss and easier handling by nurses and phlebotomy personnel. PMDA classifies open blood-collection tubes as Class II medical devices, with the Japanese nomenclature covering single-use tubes intended for blood collection, transportation or storage. Terumo has developed extensive blood-collection and diagnostic products, while Nipro and Kawasumi Laboratories contribute needles, collection systems and blood-management technologies for Japanese hospitals and blood centers. The innovation challenge is particularly relevant for elderly patients and patients requiring repeated testing, where smaller collection volumes and less traumatic needle systems can reduce patient burden. Japan’s aging healthcare environment also encourages development of closed collection systems that minimize exposure to blood and simplify transfer from the patient to the laboratory tube. In October 2024, PMDA published a revised examination guideline for open blood-collection tubes, reflecting continued refinement of technical evaluation requirements for this device category. Japanese manufacturers are consequently competing not only on tube materials and needle sharpness but also on additive stability, vacuum reliability, safety mechanisms, compatibility with automated laboratory systems and ease of use.

Recent Technology Trends Automation and specimen-quality control are becoming more important as Japanese hospitals attempt to process increasing diagnostic workloads with constrained clinical labor. Vacuum blood-collection systems remain central because they allow predetermined blood volumes to be collected directly into sealed tubes containing anticoagulants, clot activators or other additives. PMDA’s Class II classification for open blood-collection tubes and its reference to ISO 6710:2017, JIS standards and risk-management requirements demonstrate the technical emphasis placed on standardized specimen containers. Terumo and Nipro are positioned to benefit from demand for safer needles, integrated holders and closed sampling systems, while laboratories increasingly use barcode identification and automated pre-analytical equipment to reduce specimen-processing errors. The Japan Red Cross collected 5,013,064 blood donations in 2024, including 3,326,147 400-mL whole-blood donations, 1,028,506 plasma donations and 534,774 platelet donations, demonstrating the scale of blood collection requiring specialized bags, needles and related devices. For Japanese hospitals in Tokyo, Osaka and Nagoya, the technology direction is therefore toward standardized collection, lower contamination risk, improved sample traceability and compatibility with automated laboratory workflows.

Market Dynamics Market Driver: High Diagnostic Testing Volume Japan’s extensive healthcare infrastructure creates persistent demand for blood-collection devices because laboratory testing is embedded in routine diagnosis, chronic-disease monitoring, inpatient care and preventive healthcare. The country recorded 8,122 hospitals and 104,894 medical clinics in October 2023, providing more than 113,000 hospital and clinic locations where venous blood specimens can be collected. University hospitals in Tokyo, Osaka and Kyoto handle complex testing, while smaller clinics depend heavily on standardized vacuum tubes and needle systems for routine biochemical, hematological and immunological tests. Terumo and Nipro benefit from this distributed clinical demand because their products can be standardized across different healthcare facilities. The continued requirement for repeated laboratory monitoring among older patients also supports recurring consumption of single-use needles, tubes, holders and specimen containers rather than one-time equipment purchases.

Market Challenge: Healthcare Labor Constraints Japan’s demographic structure creates pressure on hospitals and clinics to achieve more diagnostic work with limited clinical staff. The country had 104,894 medical clinics and 8,122 hospitals in 2023, but maintaining staffing across this extensive network creates operational pressure, particularly outside major metropolitan areas. Blood collection requires correct patient identification, tube selection, venipuncture, filling, mixing, labeling and transport, meaning every additional manual step creates an opportunity for delay or specimen error. Terumo and Nipro therefore face demand for products that simplify collection while maintaining safety and sample quality. A Japan-specific friction point is the combination of an aging patient population with a fragmented network of more than 100,000 clinics, making standardized training and consistent device usage difficult across facilities. Devices with integrated safety features and simplified workflows can help reduce dependence on individual operator technique.



Market Trend: Safer Closed Collection Systems The Japanese market is moving toward closed, single-use and safety-oriented blood-collection systems that reduce direct exposure to blood and improve specimen handling. PMDA identifies open blood-collection tubes as Class II devices and references ISO 6710:2017 and Japanese JIS standards for their technical framework. The Japan Red Cross blood system processed more than 5 million donations in 2024, illustrating the operational scale at which closed collection and standardized disposable devices are required. Terumo, Nipro and Kawasumi Laboratories are therefore positioned around technologies including evacuated tubes, safety needles, blood bags and integrated collection assemblies. The trend is also supported by hospital infection-control practices because sealed tubes reduce unnecessary specimen exposure between collection and laboratory processing. Automation-compatible tubes with barcodes and standardized dimensions are increasingly important as large Japanese hospitals connect blood collection with automated laboratory lines.

Regulatory Framework · Japan regulates blood-collection devices under the Pharmaceuticals and Medical Devices Act (PMD Act), with PMDA providing technical evaluation and Japan’s Ministry of Health, Labour and Welfare overseeing the broader regulatory system. PMDA classifies open blood-collection tubes as Class II, meaning manufacturers must satisfy applicable certification or approval requirements before commercial distribution. The PMDA database specifies open blood-collection tubes as single-use devices intended for collection, transportation or storage of blood specimens and references ISO 6710:2017, JIS T 0993-1:2020, JIS T 3233:2023 and JIS T 62366-1:2022. Manufacturers such as Terumo, Nipro and Kawasumi Laboratories therefore need documented quality systems, risk management and performance verification for products supplied to hospitals, laboratories and blood centers.

· Transfusion-related collection equipment is subject to additional requirements because blood products are managed through Japan’s national blood-supply framework, with the Japan Red Cross operating 7 block blood centers and 115 blood donation rooms. The Japan Red Cross reported 5,013,064 donations during 2024, creating a large operational requirement for collection needles, blood bags and associated sterile equipment. MHLW oversees Japan’s blood-policy framework, while the Japan Red Cross manages collection, testing, manufacturing and supply activities. Device manufacturers supplying this ecosystem must therefore satisfy both medical-device requirements and the operational specifications of transfusion institutions.

Segment Analysis By Product Type Blood collection devices include needles, evacuated blood-collection tubes, syringes, lancets, blood bags, holders and integrated collection sets. Evacuated tubes are widely used for diagnostic venous sampling because predetermined vacuum volumes allow standardized specimen collection, while needles and holders form the patient-interface portion of the system. PMDA classifies open blood-collection tubes as Class II, with their intended use covering blood specimen collection, transportation and storage. Terumo and Nipro have strong positions in disposable medical devices, while Kawasumi Laboratories is associated with blood-management products. Japan’s Red Cross collection network creates an additional large requirement for blood bags and collection assemblies, with more than 5 million donations in 2024. Product selection depends on whether the end use is routine laboratory testing, emergency medicine, transfusion collection or specialized diagnostic sampling.

By Device Type Vacuum blood-collection systems represent a core diagnostic segment because hospitals and clinics require consistent sample volumes for chemistry, hematology and immunological testing. Syringe-based collection remains relevant where vacuum collection is unsuitable, while capillary devices are used for selected tests requiring small blood volumes. PMDA’s blood-gas sampling syringe category is designated Class II, with the device intended to collect arterial blood for blood-gas measurement. This creates a specialized segment serving intensive-care units, emergency departments and respiratory-care departments at institutions such as University of Tokyo Hospital and Osaka University Hospital. Terumo and Nipro can address multiple collection formats, allowing healthcare providers to standardize procurement across routine and specialized clinical departments.

By Application Diagnostic blood collection is the largest application base because blood specimens are required for routine chemistry, hematology, infectious-disease testing, hormone analysis and chronic-disease monitoring across Japan’s 8,122 hospitals and 104,894 clinics. Transfusion collection represents another major application, with the Japan Red Cross reporting more than 5.0 million donations in 2024. Blood-gas sampling creates a specialized application for emergency and intensive-care settings, with PMDA identifying dedicated arterial blood-gas collection syringes as Class II devices. Terumo, Nipro and other suppliers therefore serve different technical requirements ranging from routine outpatient phlebotomy to high-volume donor collection and critical-care diagnostics.

By End User Hospitals remain major users because inpatient departments, emergency rooms, operating theatres and laboratories require blood collection throughout the day. Japan had 8,122 hospitals in October 2023, while clinics accounted for another 104,894 facilities, making outpatient healthcare an equally important consumption channel. University hospitals in Tokyo and Osaka require advanced collection systems for specialized diagnostics, while community clinics require standardized and economical tubes and needles. The Japan Red Cross forms a distinct end-user group through its 115 blood donation rooms and 271 mobile collection vehicles, requiring devices optimized for high-volume donor throughput. Nursing homes, diagnostic laboratories and health-screening centers create additional demand for routine specimen-collection products.

By Material Plastic polymers dominate disposable blood-collection products because they provide lower breakage risk and support lightweight single-use devices, while glass remains relevant for selected laboratory applications requiring specific chemical or dimensional properties. PMDA’s technical definition of blood-collection tubes recognizes both plastic and glass construction in related sampling-device categories, while its standards framework references ISO 6710 and Japanese JIS requirements. Terumo, Nipro and Japanese laboratory suppliers therefore develop materials around vacuum stability, additive compatibility, transparency, dimensional consistency and sterilization requirements. Material selection is particularly important for anticoagulant-containing tubes because the container must preserve specimen quality during collection and transportation. Japanese laboratories also increasingly require tubes compatible with automated analyzers, making dimensional and material consistency commercially important.

By Distribution Channel Hospitals and large laboratory networks generally procure blood-collection devices through medical-device distributors, direct manufacturer contracts and centralized purchasing systems, while smaller clinics depend more heavily on regional distributors. Terumo and Nipro use established Japanese healthcare-sales networks to reach hospitals in Tokyo, Osaka, Nagoya and regional cities, while the Japan Red Cross operates a centralized blood-service structure through 7 block blood centers. The distribution model places strong emphasis on reliable recurring supply because needles, tubes and other blood-collection products are single-use consumables. A supply interruption can affect laboratory operations immediately, so Japanese hospitals typically value stable inventory, standardized specifications and validated compatibility alongside unit price.

Considered in this report
Historic Year: 2020
Base Year: 2025
Estimated Year: 2026
Forecast Year: 2031

Aspects covered in this report
Japan Blood Collection Devices Market with its value and forecast along with its segments
Various drivers and challenges
Ongoing trends and developments
Top profiled companies
Strategic recommendation

By Product Type

Blood collection devices
Evacuated tubes
Terumo and Nipro

By Device Type

Syringe-based collection
PMDA’s blood-gas sampling syringe category

By Application

Diagnostic blood collection
Transfusion collection

By End User

Hospitals
University hospitals in Tokyo and Osaka

By Material

Plastic polymers dominate disposable blood-collection products because they
Material selection

By Distribution Channel

Terumo and Nipro